Designing quinoline-isoniazid hybrids as potent anti-tubercular agents inhibiting mycolic acid biosynthesis

Author:

Alcaraz Matthéo,Sharma Bharvi,Roquet-Banères Françoise,Conde CyrilORCID,Cochard ThierryORCID,Biet FranckORCID,Kumar VipanORCID,Kremer LaurentORCID

Funder

Ministere de l'Enseignement superieur de la Recherche et de l'Innovation

Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation

Council of Scientific and Industrial Research, India

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference59 articles.

1. Reconsidering Mycobacterium bovis as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance study;Duffy;Lancet Microbe,2020

2. GBD 2019 Tuberculosis Collaborators, Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019;Lancet Infect. Dis.,2021

3. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis;Dheda;Lancet Respir. Med.,2017

4. The quest for the holy grail: new antitubercular chemical entities, targets and strategies;Huszár;Drug Discov. Today,2020

5. The challenge of new drug discovery for tuberculosis;Koul;Nature,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3